参考文献: [1] WILD S, ROGLIC G, GREEN A, et al. Global Prevalence of Diabetes: Estimates for the Year 2000 and Projections for 2030. Diab Care 2004; 27:1047-53.[2] ZIMMED P, KGMM. SHOW A and J. Global and Societal Implications of the Diabetes Epidemic [J]. Nature, 2001, 414(13): 782-787.[3] CLARE D A, SWAIDOOD H E. Bioactive Milk Peptides: a Prospectus [J]. Journal of Dairy Science, 2000, 83(6): 1187-1195.[4] KHANNA P, JAIN S C, PANAGARIYA A, et al. Hypoglycemic Activity of Polypeptide from a Plant Source[J]. J N at Prod, 1981,44 (6) : 648 - 655.[5] 盛清凯,姚惠源.苦瓜多肽-P的分离及其降糖活性[J]. 无锡轻工大学学报,2005,24(1):49-51.[6] 盛清凯,赵红波,刘俊珍,等.苦瓜降糖多肽-P对2型糖尿病模型鼠血糖血脂的影响[J]. 山东农业大学学报(自然科学版),2008,39 (1):23-25.[7] 盛清凯,姚惠源.苦瓜子中植物胰岛素的降糖作用[J].江苏农业科学,2004,6: 163-165.[8] 刘红雨,付中平,周吉燕,等.苦瓜降糖多肽PA对四氧嘧啶糖尿病小鼠的口服降血糖作用[J].中药药理与临床,2009, 25 (4):32-35.[9] CHOI K. Botanical Characteristics, Pharmacological Effects and Medicinal Components of Korean Panax Ginseng C A Meyer [J]. Acta Pharmacol Sin, 2008, 29(9):110921018.[10] ANDO T, MURAO K, YAMASKI N, et al. Preparation of Antilipolytic Substance from Panax Ginseng [J]. Res. A, 1980, 38:18.[11] 张今,张红缨,陈冬松,等.人参多肽基因的化学合成和克隆[J].生物化学杂志,1990,(6):193-197.[12] 王本样,杨明,金玉莲,等.人参多肤降血糖作用[J].药学学报,1990,25(6):401-405.[13] 葛焕琦,蔡寒青,王涛,等.人参糖肽注射液治疗2型糖尿病30例[J].吉林大学学报(医学版),2003,29(2):206-207[14] 石燕玲,何慧,张胜,等.灵芝肽对免疫性肝损伤小鼠的保护作用[J]. 食品科学,2008, 29(6):415-418.[15] 张胜,何慧,韩园园,等.灵芝肽诱导人肝癌HepG2细胞凋亡的研究[J].菌物学报,2010, 29(3): 442-448.[16] 孙颉,何慧,谢笔钧.灵芝肽对实验性糖尿病小鼠的治疗作用[J].食品科学,2002,23(11):133-135.[17] 赵海英,梁程超,缪锦来,等.鳕鱼皮胶原蛋白的制备及其成分分析[J].中国海洋药物杂志,2005,24(5):30-32.[18] 朱翠凤,韩晓龙,张帆,等.海洋骨胶原肽对去卵巢大鼠体质量以及胰腺细胞凋亡和组织病变的影响[J].中国老年学杂志,2007,27(11):1046-1049.[19] 王军波,张召锋,裴新荣.海洋胶原肽对高胰岛素血症模型大鼠糖脂代谢的影响[J]. 卫生研究,2010,39(2):143-146.[20] 王秀丽,刘安军,李琨,等.胶原蛋白多肽-铬(Ⅲ)螯合物的降血糖机理探讨[J].食品研究与开发, 2006, 27(5):125-126.[21] SHINDEA U A, ShARMA G, XU Y J. Insulin Sensitizing Action of Chromium Picolinate in Various Experimental Models of Diabetes Mellitus[J]. J Trace Elem Med Biol, 2004, 18(1): 23-32.[22] SPRANGER J, KROKE A, MOJLIG M, et al. Inflammatory Cytokines and the Risk to Develop Type 2 Diabetes: Results of the Prospective Population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Diabetes 2003;52(3):812-817.[23] 刘桂琴,朱翠凤,李艳飞等.海洋胶原肽对2型糖尿病大鼠过氧化应激标志物表达的影响[J].中国组织工程研究与临床康复,2008, 12(23):4469-4472.[24] 黄凤杰,吴梧桐.鲨鱼肝活性肽 S28300抗糖尿病与细胞保护作用[J].中国临床药理学与治疗学,2007,12(11):1283-1287.[25] 王立晖,袁永俊,李培骏,等.乳源酪啡肽的研究进展[J].食品研究与开发, 2006,27(4):169-171.[26] FROETSCHEL M A. Bioactive Peptides in Digesta that Regulate Gastrointestinal Function and Intake [J]. Animal Science, 1996, 74: 2 500-2 508.[27] 宗亚峰. β酪啡肽在大鼠胃肠道内的释放、吸收和稳定特性及其对胃肠机能的影响[D]. 南京: 南京农业大学, 2007: 104-107.[28] 印虹,马畅,韩东宁,等.乳源β-酪啡肽-7对高血糖大鼠小肠黏膜氧化应激的影响[J]. 食品科学, 2011, 32(3):208-211.[29] HAN J, INOUE S, ISODA H. Effects of Silkworm Powder on Glucose Absorption by Human Intestinal Epithelial Cell Line Caco-2[J]. Journal of Natural Medicines, 2007, 61(4):387–390.[30] 刘金明,傅志强,桂仲争,等. 家蚕幼虫蛋白水解液的研制及其降血糖效果初探[J]. 蚕业科学, 2007,33(4):689-693.[31] 郭芳彬. 蜂产品与糖尿病[J]. 养蜂科技, 2004(2): 31-35.[32] 盛晟,周杰,等. 蜂蛹富肽蛋白粉对大鼠免疫功能和血糖、血脂的影响[J]. 食品科学, 2010, 31(3):250-252.[33] BELL G I, LAYBOURN P J, NAJARIAN R C, et al. Exon Duplication and Divergence in the Human Preproglucagon Gene[J].Nature,1983,304(5924):368-371.[34] 李宗杰, 车巧林, 杨丽萍.促胰岛素释放肽和GLP-1类似物研究进展[J]. 生命科学研究,2006,10(2):115-122.[35] HOU J, YAN R , DING D , et al. Oral Administrtion of a Fusion Protein Containing Eight GLP-1 Analogs Produced in Escherichia ColiBL21 in Strptozotocin-induced Diabetic Rats[J]. Biotechnol Lett, 2007, (29): 1436-1446.[36] ZHAO L, LIAO F, WANG C Y, et al. Generation of Transgenic Cucumbers with Expression of a Ten-tandem Repeat Long-acting GLP-1 Analogue and Their Biological Function on Diabetic Rats. Chinese Science Bulletin, 2009, 54: 4658-4663.[37] ENG J , KLEINMAN W A , SINGH I , et a1. Isolation and Characterization of Exendin-4, an Exendin-3 Analogue , from Heloderma Suspectum Venom: Further Evidence for an Exendin Receptor on Dispersed Acini from Guinea Pig Pancreas[J]. Biol Chem, 1992, 267: 7402(11) : 74022-74061.[38] CHEN J, YU L, WANG L, et al. Stability of Synthetic Exendin-4 in Human Plasma in Vitro[J]. Protein Pept Lett, 2007, 14 (1) :19.[39] BUSE J B, KLONOFF D C, NIELSEN L L , et al. Metabolic Effects of Two Years of Exenatide Treatment on Diabetes, Obesity, and Hepatic Biomarkers in Patients with Type 2 Diabetes : an Interim Analysis of Data from the Open-label , Uncontrolled Extension of Three Double-blind, Placebo-controlled Trials [J]. Clin Ther, 2007,29:139.[40] David R J. Molecular, Pharamacological and Clinical Aspect of Liraglutide [J]. Molecular and Cellular Endocrinology.2009, (297): 137-140. |